×
About 4,190 results

ALLMedicine™ Crohn Disease Center

Research & Reviews  1,390 results

Pyostomatitis Vegetans With Orofacial and Vulvar Granulomatosis in a Pediatric Patient.
https://doi.org/10.12788/cutis.0676
Cutis Nelson R, Love L et. al.

Feb 4th, 2023 - Pyostomatitis vegetans (PSV) is a rare disorder strongly associated with inflammatory bowel disease (IBD), most commonly ulcerative colitis, but has infrequently been found in patients with Crohn disease (CD). We present the case of a 7-year-old g...

Bacterial Sepsis Clinical Presentation
https://emedicine.medscape.com/article/234587-clinical

Feb 3rd, 2023 - History According to Surviving Sepsis Campaign Guidelines 2021, new changes have been made to the guidelines. [1] Next: History and Physical Examination Nonspecific signs and symptoms The history and physical examination findings are nonspecific b...

Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases.
https://doi.org/10.1097/PAI.0000000000001096
Applied Immunohistochemistry & Molecular Morphology : AIMM; Hamamoto Y, Kawamura M et. al.

Feb 3rd, 2023 - Ulcerative colitis (UC) and Crohn disease (CD) are cryptogenic inflammatory bowel diseases that are suggestive of aberrant mucin (MUC) expression; however, their relationship remains unclear. Here, we examined aberrant MUC expression in intestinal...

Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn Disease
https://clinicaltrials.gov/ct2/show/NCT05710276

Feb 2nd, 2023 - The assessment of digestive inflammation and disease activity in paediatrics Crohn's disease (CD) is currently based on anamnestic, clinical and paraclinical elements such as the paediatric CD activity index (wPCDAI) , faecal calprotectin measurin...

Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers i...
https://doi.org/10.1002/cncr.34663
Cancer Hemminki K, Sundquist K et. al.

Jan 31st, 2023 - Autoimmune diseases are associated with many cancers but there is a lack of population-based studies with different autoimmune diseases that have a long follow-up. This is also true of hepatobiliary cancers, which include hepatocellular cancer (HC...

see more →

Guidelines  4 results

ACR Appropriateness Criteria® Crohn Disease-Child.
https://doi.org/10.1016/j.jacr.2022.02.020
Journal of the American College of Radiology : JACR; , Moore MM et. al.

May 14th, 2022 - Crohn disease is an inflammatory condition of the gastrointestinal tract with episodes of exacerbation and remission occurring in children, adolescents, and adults. Crohn disease diagnosis and treatment depend upon a combination of clinical, labor...

ACR Appropriateness Criteria® Crohn Disease.
https://doi.org/10.1016/j.jacr.2020.01.030
Journal of the American College of Radiology : JACR; , Kim DH et. al.

May 7th, 2020 - Three common clinical scenarios involving use of imaging in Crohn disease are covered. These include the initial evaluation of Crohn disease when the diagnosis has not been previously established, the evaluation for anticipated exacerbation of kno...

European Society of Paediatric Radiology abdominal imaging task force: statement on ima...
https://doi.org/10.1007/s00247-019-04375-8
Pediatric Radiology; Watson TA, Petit P et. al.

Mar 28th, 2019 - Very early onset inflammatory bowel disease (VEO-IBD) is defined as disease presenting before the age of 6. These children require a tailored imaging approach because conventional imaging studies can be difficult to perform at such a young age. Un...

Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Po...
https://doi.org/10.1097/MPG.0000000000001562
Journal of Pediatric Gastroenterology and Nutrition; Amil-Dias J, Kolacek S et. al.

Mar 8th, 2017 - The incidence of Crohn disease (CD) has been increasing and surgery needs to be contemplated in a substantial number of cases. The relevant advent of biological treatment has changed but not eliminated the need for surgery in many patients. Despit...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  65 results

Assessment of Intestinal Inflammation by Infrared Thermography in Pediatric Crohn Disease
https://clinicaltrials.gov/ct2/show/NCT05710276

Feb 2nd, 2023 - The assessment of digestive inflammation and disease activity in paediatrics Crohn's disease (CD) is currently based on anamnestic, clinical and paraclinical elements such as the paediatric CD activity index (wPCDAI) , faecal calprotectin measurin...

Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
https://clinicaltrials.gov/ct2/show/NCT03278912

Jan 25th, 2023 - Over 1 million people suffer from IBD in the United States. Although the exact pathogenesis is unclear, IBD results from an inappropriate inflammatory response to intestinal microbes which is influenced by the environment in a genetically suscepti...

Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease
https://clinicaltrials.gov/ct2/show/NCT03983837

Jan 20th, 2023 - Chronic granulomatous disease (CGD) is a rare genetic immune disorder that results in recurrent and severe infections, and inflammatory dysregulation. For almost 50% of patients with CGD, this inflammation causes severe inflammatory bowel disease ...

Inflammatory Bowel Disease Related Joint Manifestations
https://clinicaltrials.gov/ct2/show/NCT05693311

Jan 20th, 2023 - Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder divided into two large types Crohn disease and ulcerative colitis. Crohn disease may affect any part of the gastrointestinal tract (GIT), whereas Ulcerative colitis affects the...

Loss of RESponse to Ustekinumab Treated by Dose Escalation
https://clinicaltrials.gov/ct2/show/NCT04245215

Dec 14th, 2022 - The study is a prospective double blind interventional study in patients with Crohn Disease treated with ustekinumab that show an objective secondary loss of response to ustekinumab after induction treatment (>Week 16). Patients can be screened du...

see more →

News  208 results

Exophytic Firm Papulonodule on the Labia in a Patient With Nonspecific Gastrointestinal Symptoms
https://www.mdedge.com/dermatology/article/260635/dermatopathology/exophytic-firm-papulonodule-labia-patient-nonspecific
Gabrielle M. Peck, BA, Joy Mosser-Goldfarb, MD

Jan 17th, 2023 - The Diagnosis: Cutaneous Crohn Disease Kinyoun and Grocott-Gomori methenamine-silver staining of the labial biopsy were negative for mycobacteria and fungi, respectively. A complete blood cell count, erythrocyte sedimentation rate, C-reactive prot.

Pyostomatitis Vegetans With Orofacial and Vulvar Granulomatosis in a Pediatric Patient
https://www.mdedge.com/dermatology/article/260302/pediatrics/pyostomatitis-vegetans-orofacial-and-vulvar-granulomatosis
Rachel Nelson, MD, Lauren Love, MD et. al.

Dec 20th, 2022 - Case Report A 7-year-old girl who was otherwise healthy was referred by pediatric gastroenterology for evaluation of cutaneous Crohn disease (CD). The patient had a 4-year history of persistent lip swelling and a 3-year history of asymmetric eryth.

Severe abdominal pain and vomiting
https://www.mdedge.com/uc-crohn-disease-challenge-center/article/258756/uc-crohn-disease/severe-abdominal-pain-and-vomiting

Oct 20th, 2022 - On the basis of the patient’s family history, personal history, and presentation, the likely diagnosis is Crohn disease. Although the disease may be diagnosed at any age, onset shows a bimodal distribution, with the first, more predominant wave oc.

Incidence and Risk Factors for Biliary Tract Cancers
https://www.onclive.com/view/incidence-and-risk-factors-for-biliary-tract-cancers

Oct 11th, 2022 - Transcript: Milind Javle, MD: Before we get there, Anjana, you mentioned that you’re seeing more patients in your clinic now, and that’s also my experience. We’re seeing a lot more biliary cancer, and I’m amazed that some fellows come to my clini...

Vedolizumab-Induced Acne Fulminans: An Uncommon and Severe Adverse Effect
https://www.mdedge.com/dermatology/article/258465/acne/vedolizumab-induced-acne-fulminans-uncommon-and-severe-adverse
Kaitlin Blankenship, MD, Laura Burns, MD et. al.

Oct 6th, 2022 - To the Editor: Vedolizumab is an innovative monoclonal antibody targeted against the α4β7 integrin that is approved for treatment of moderate to severe ulcerative colitis and Crohn disease refractory to standard treatment. 1 Vedolizumab is thought.

see more →

Patient Education  2 results see all →